Women with endometriosis may soon experience shorter diagnostic wait times thanks to new tests being endorsed for use by General Practitioners (GPs). The National Institute for Health and Care Excellence (NICE) has given approval to two non-invasive tests that have the potential to significantly reduce the current average diagnosis wait time of over nine years.
Endometriosis, a painful condition affecting approximately one in 10 women of reproductive age in the UK, involves the growth of cells resembling those in the womb lining in other parts of the body. Symptoms include severe pelvic pain, heavy periods, fatigue, and infertility.
The two approved tests, EndoSure and Endotest, are set to be implemented in NHS practices for a three-year trial period while further evidence on their effectiveness is gathered. Endotest analyzes saliva samples for microRNAs associated with endometriosis, while EndoSure measures gut electrical signals using abdominal sensor pads.
Although neither test is meant to diagnose endometriosis independently, they are expected to aid in identifying individuals requiring further evaluation, potentially leading to earlier treatment initiation.
This development follows a survey conducted by the All-Party Parliamentary Group on Endometriosis, revealing that more than half of the 10,000 surveyed women had visited their GP over ten times before receiving a diagnosis. Additionally, more than half had sought treatment at A&E due to their symptoms.
Dr. Anastasia Chalkidou, NICE’s healthtech program director, emphasized the significance of these tests in expediting endometriosis diagnosis, potentially alleviating the chronic pelvic pain that affects daily life for many women.
One individual who benefited from the new tests is Simran Chavda, a 15-year-old from Huddersfield, West Yorkshire, who struggled with severe pelvic pain for years before receiving a diagnosis through the gut test. Her positive experience highlights the potential impact of early diagnosis and treatment for individuals with endometriosis.
Healthcare professionals, including Dr. Gail Busby, a consultant gynaecologist at Manchester University NHS Foundation Trust, have expressed optimism about the tests’ ability to improve the lives of individuals affected by endometriosis and optimize healthcare resource allocation.
The endorsement of these tests represents a step towards more efficient and timely diagnosis of endometriosis, offering hope to women who have endured prolonged diagnostic journeys.
